Brief: China NT Pharma Group updates on approval of new drug to enter market
03/01/2017 23:56
Jan 4 (Reuters) - China Nt Pharma Group Co Ltd 1011.HK
* A new drug developed by unit has obtained approval from
china food and drug administration to enter market
Source (http://bit.ly/2ixiaKe)
Further company coverage: 1011.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY